chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Pain
Clinical narrative: soreness at injection site; tired; joint pain; feverish; aches; headache; This is a spontaneous report from a contactable consumer(patient). A 61 year old female received bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on 16Apr2021 at 11:30 am in right arm as dose 2, single for covid-19 immunization (at the age of 61 year old). The patient medical history included penicillin allergy. Concomitant medications were not reported. The patient previously took bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on 26Mar2021 as DOSE 1, SINGLE for covid-19 immunization (at the age of 61 year) and experienced soreness at injection site. It was reported that patient was non pregnant at the time of vaccination and did not receive any vaccination in four weeks. The patient did not suffer from Covid prior to vaccination and did not undergo covid test post vaccination. On 16Apr2021 at 21:00 the patient experienced vaccination site pain, feverish, joint pain, headache, tired and aches. Soreness at injection site was noticeable but not enough to hamper movement. Beginning of joint pain was Throughout the night. Body aches was until early afternoon, injection site was still sore. On Apr2021 the patient underwent lab test and procedures which included body temperature and diagnosed with temp of 100.8 at 7:00AM, 9AM temp of 99.3, 9:30am temp of 98.3, On 17 Apr2021 temp of 100.5, 8:30 pm temp of 101.4, 10 pm temp of 100.5 Sunday (two days later); 1:30am temp of 100.00, 8:10AM of 97.7. Therapeutic measures were taken for the AE headache and treatment was given with aspirin . The clinical outcome of the events was recovered on an unspecified day in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: soreness at injection site; tired; joint pain; feverish; aches; headache; This is a spontaneous report from a contactable consumer(patient). A 61 year old female received bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on 16Apr2021 at 11:30 am in right arm as dose 2, single for covid-19 immunization (at the age of 61 year old). The patient medical history included penicillin allergy. Concomitant medications were not reported. The patient previously took bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on 26Mar2021 as DOSE 1, SINGLE for covid-19 immunization (at the age of 61 year) and experienced soreness at injection site. It was reported that patient was non pregnant at the time of vaccination and did not receive any vaccination in four weeks. The patient did not suffer from Covid prior to vaccination and did not undergo covid test post vaccination. On 16Apr2021 at 21:00 the patient experienced vaccination site pain, feverish, joint pain, headache, tired and aches. Soreness at injection site was noticeable but not enough to hamper movement. Beginning of joint pain was Throughout the night. Body aches was until early afternoon, injection site was still sore. On Apr2021 the patient underwent lab test and procedures which included body temperature and diagnosed with temp of 100.8 at 7:00AM, 9AM temp of 99.3, 9:30am temp of 98.3, On 17 Apr2021 temp of 100.5, 8:30 pm temp of 101.4, 10 pm temp of 100.5 Sunday (two days later); 1:30am temp of 100.00, 8:10AM of 97.7. Therapeutic measures were taken for the AE headache and treatment was given with aspirin . The clinical outcome of the events was recovered on an unspecified day in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Urticaria
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old (non-pregnant) female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EW0172), at the age of 40, via an unspecified route of administration, in left arm, on Apr 23, 2021, at 04:00 pm, single dose, for COVID-19 immunization. Patient previously received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# EW0153), via an unspecified route of administration, in left arm, on Apr 2, 2021, at 04:00 pm, single dose, for COVID-19 immunization. The patient's medical history not reported. Concomitant medications included Tylenol (paracetamol), cefixime, Flexeril and Toradol (ketorolac tromethamine) for an unspecified indication, start and stop date not reported. Patient did not have COVID-19 prior vaccination. Patient has not undergone a COVID-19 test post vaccination. Patient had not received any other vaccine in four weeks. On Apr 25, 2021, at 12:00 pm, patient experienced hives (on neck, chest, stomach, back and upper arms); bad taste in mouth and fatigue. Patient received treatment with hydrocortisone cream. The outcome of events recovered with lasting effects on unspecified date in 2021. No follow-up attempts possible. No further information expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperaesthesia, Pain, Swelling
Clinical narrative: body aches; headache; skin sensitivity; swelling; This is a spontaneous report from a contactable consumer (Patient) reported that:  A 28-years-old female patient (non-pregnant) received bnt162b2 (PFIZER BIONTECH COVID-19 Vaccine, Solution for injection, Batch/Lot Number: ER8732) via an unspecified route of administration, administered in Arm Left on 27Apr2021 14:15 (Age at vaccination 28-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included obesity. The patient was allergies to amoxicillin and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included aleve and excedrin extra strength. The patient received other medications within 2 weeks of vaccination. Patient previously received bnt162b2 (PFIZER BIONTECH COVID-19 Vaccine, Solution for injection, Batch/Lot Number: ER8733) via an unspecified route of administration, administered in Arm Left on 06Apr2021 14:15 (Age at vaccination-28-years-old) as DOSE 1, SINGLE for COVID-19 immunization. On 27Apr2021 05:00PM, the patient had experienced body aches, headache, skin sensitivity and swelling. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient has not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Headache, Maternal exposure during pregnancy, Pain
Clinical narrative: Soreness in injection site; Soreness in armpit; Fatigue; Body aches; Headache; Pregnant at the time of vaccination?: Yes/ Gestation period: 10 weeks; This is a spontaneous report from a non-contactable consumer (patient). This consumer or other non hcp reported information for mother. This is a maternal report.   A 35-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8731), via an unspecified route of administration, administered in Arm Left on 14Apr2021 09:00 (35-years-old at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing and Known allergies: Sulfa medication. Concomitant medications included prenatal vitamin (manufacturer unknown) and loratadine (CLARITIN), both taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 09:15 (at the age of 35-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 09:00, the patient experienced pregnant at the time of vaccination?: yes/ gestation period: 10 weeks. On 14Apr2021 12:00, the patient experienced soreness in injection site, soreness in armpit, fatigue, body aches, headache. The mother reported she became pregnant while taking bnt162b2. The mother was 10 Weeks pregnant at the onset of the event. The outcome of event pregnant at the time of vaccination?: yes/ gestation period: 10 weeks was unknown. The clinical outcome of the events soreness in injection site, soreness in armpit, fatigue, body aches and headache were resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in injection site; Soreness in armpit; Fatigue; Body aches; Headache; Pregnant at the time of vaccination?: Yes/ Gestation period: 10 weeks; This is a spontaneous report from a non-contactable consumer (patient). This consumer or other non hcp reported information for mother. This is a maternal report.   A 35-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8731), via an unspecified route of administration, administered in Arm Left on 14Apr2021 09:00 (35-years-old at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing and Known allergies: Sulfa medication. Concomitant medications included prenatal vitamin (manufacturer unknown) and loratadine (CLARITIN), both taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 09:15 (at the age of 35-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 09:00, the patient experienced pregnant at the time of vaccination?: yes/ gestation period: 10 weeks. On 14Apr2021 12:00, the patient experienced soreness in injection site, soreness in armpit, fatigue, body aches, headache. The mother reported she became pregnant while taking bnt162b2. The mother was 10 Weeks pregnant at the onset of the event. The outcome of event pregnant at the time of vaccination?: yes/ gestation period: 10 weeks was unknown. The clinical outcome of the events soreness in injection site, soreness in armpit, fatigue, body aches and headache were resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Inappropriate schedule of product administration, Myalgia, Overdose
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 56-years old female patient received BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was unknown) via unspecified route of administration in right arm as dose 2, single on 29Mar2021 for covid-19 immunization. The patient age at vaccination was 59 years. The patient medical history included ulcerative colitis. The patient has Covid prior vaccination. The patient concomitant medications included lyaldia and levothyroxine. The Historical vaccination included BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was unknown) in left arm as dose 1, single on 29Mar2021 for covid-19 immunization, the patient experienced Very sharp pains in right hip joint and abdomen on her Dose 1. On 23Apr2021, The patient experienced Right thumb muscle/joint was so sore that I couldn't Grip using my thumb and on 29Mar2021, the patient administered dose 1 on 29Mar2021 and dose 2 on 29Mar2021. The Patient was not received the treatment. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Fatigue, Myalgia, Nasal congestion
Clinical narrative: weird taste in mouth; pain and swelling in armpit; pain and swelling in armpit; Fatigue; extreme joint and muscle pain; extreme joint and muscle pain; congestion; This is a spontaneous report from a non-contactable consumer (patient). A 51-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiry date were not reported) via an unspecified route of administration on 20Apr2021 09:30 as dose 2, single for COVID-19 immunization. The patient medical history included allergic to artichokes from an unknown date and unknown if ongoing. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/Lot Number and Expiry date was not reported) via an unspecified route of administration on an unspecified date at 09:30 on an unspecified date in Mar2021 for COVID-19 immunization and experienced menstrual period after first injection more painful. The patient reported had not diagnose with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. On 20Apr2021, the patient experienced fatigue, extreme joint and muscle pain, and congestion. On 22Apr2021, patient experienced pain and swelling in armpit, and weird taste in mouth on 23Apr2021. No treatment was taken for the events. The outcome of the events was reported as recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Taste disorder
Clinical narrative: weird taste in mouth; pain and swelling in armpit; pain and swelling in armpit; Fatigue; extreme joint and muscle pain; extreme joint and muscle pain; congestion; This is a spontaneous report from a non-contactable consumer (patient). A 51-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiry date were not reported) via an unspecified route of administration on 20Apr2021 09:30 as dose 2, single for COVID-19 immunization. The patient medical history included allergic to artichokes from an unknown date and unknown if ongoing. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/Lot Number and Expiry date was not reported) via an unspecified route of administration on an unspecified date at 09:30 on an unspecified date in Mar2021 for COVID-19 immunization and experienced menstrual period after first injection more painful. The patient reported had not diagnose with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. On 20Apr2021, the patient experienced fatigue, extreme joint and muscle pain, and congestion. On 22Apr2021, patient experienced pain and swelling in armpit, and weird taste in mouth on 23Apr2021. No treatment was taken for the events. The outcome of the events was reported as recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Headache, Myalgia, Pain, Pyrexia
Clinical narrative: muscle aches and pains; Headache; muscle aches and pains; Fever; Burning eyes; This is a spontaneous report from a contactable consumer (patient). A 47-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 23Apr2021 15:00 (at the age of 47-year-old) as DOSE 2, SINGLE for covid-19 immunization. Historical vaccine included bnt162b2 (BNT162B2) dose 1, administered in Arm left on 02Apr2021 01:45 PM (at the age of 47-year-old). No other vaccine in four weeks and no allergies. Medical history included hashimoto's from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. On 24Apr2021 05:00 the patient experienced muscle aches and pains, headache, muscle aches and pains, fever, burning eyes. No Covid prior vaccination and no Covid tested post vaccination. The patient not received treatment. The outcome of events was not recovered.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Eye pain, Eye pruritus, Headache
Clinical narrative: Eye pain & itchy & puffy; Eye pain & itchy & puffy; Eye pain & itchy & puffy; itchy face & neck & torso; sharp shoulder pain; greatly increased leg numbness & back pain; greatly increased leg numbness & back pain; hurts to lift left arm for a few days; bad sulfur body odor smelled by self & others for a few days; mild headaches; This is a spontaneous report from a contactable consumer (patient).  A 57-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: Ew0164), via an unspecified route of administration, administered in Arm Left on 21Apr2021 17:00 (57-years-old at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included spinal stenosis from, fibromyalgia, mycotic allergy from an unknown date and unknown if ongoing and Known allergies of Molds. The patient previously took amoxicillin and experienced drug hypersensitivity, neurontin and experienced drug hypersensitivity. Concomitant medication included fentanyl, hydrocodone bitartrate, paracetamol (NORCO), methocarbamol (ROBAXIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took unspecified dose number of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: Ew0150), via an unspecified route of administration, administered in Arm Left on 31Mar2021 as unspecified dose number, SINGLE for covid-19 immunisation and experienced sulfur body smell, arm pain, sharp pain to little fingers on both hands, headache, itchy face & neck & torso for several days. On 21Apr2021 18:00, the patient experienced eye pain & itchy & puffy, itchy face & neck & torso, sharp shoulder pain, greatly increased leg numbness & back pain, hurts to lift left arm for a few days, bad sulfur body odor smelled by self & others for a few days, mild headaches. The patient has not been tested positive prior to vaccination and post vaccination. Treatment was not received for the events. The outcome of events was not recovered.  No follow-up attempts are required. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Parosmia, Periorbital swelling, Pruritus
Clinical narrative: Eye pain & itchy & puffy; Eye pain & itchy & puffy; Eye pain & itchy & puffy; itchy face & neck & torso; sharp shoulder pain; greatly increased leg numbness & back pain; greatly increased leg numbness & back pain; hurts to lift left arm for a few days; bad sulfur body odor smelled by self & others for a few days; mild headaches; This is a spontaneous report from a contactable consumer (patient).  A 57-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: Ew0164), via an unspecified route of administration, administered in Arm Left on 21Apr2021 17:00 (57-years-old at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included spinal stenosis from, fibromyalgia, mycotic allergy from an unknown date and unknown if ongoing and Known allergies of Molds. The patient previously took amoxicillin and experienced drug hypersensitivity, neurontin and experienced drug hypersensitivity. Concomitant medication included fentanyl, hydrocodone bitartrate, paracetamol (NORCO), methocarbamol (ROBAXIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took unspecified dose number of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: Ew0150), via an unspecified route of administration, administered in Arm Left on 31Mar2021 as unspecified dose number, SINGLE for covid-19 immunisation and experienced sulfur body smell, arm pain, sharp pain to little fingers on both hands, headache, itchy face & neck & torso for several days. On 21Apr2021 18:00, the patient experienced eye pain & itchy & puffy, itchy face & neck & torso, sharp shoulder pain, greatly increased leg numbness & back pain, hurts to lift left arm for a few days, bad sulfur body odor smelled by self & others for a few days, mild headaches. The patient has not been tested positive prior to vaccination and post vaccination. Treatment was not received for the events. The outcome of events was not recovered.  No follow-up attempts are required. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Myalgia
Clinical narrative: Pain and soreness in arm at injection site down through to fingers; redness welt at injection site; headache; joint and muscle pain; joint and muscle pain; fatigue; 100.8°F fever; Pain and soreness in arm at injection site down through to fingers; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 47-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0171), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 at 10:15 (age at vaccination: 47 year) as dose 2, single for covid-19 immunisation. Medical history included migraine headache, allergen induced asthma from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (IBUPROFEN) and cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) both were taken for an unspecified indication, start and stop date were not reported. If other vaccine in four weeks reported as no. other medication reported as ibuprofen, Zyrtec. Known allergies reported as no. If covid prior vaccination and If covid tested post vaccination reported as no. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0151), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 10:15 (age at vaccination: 47 year) as dose 1, single for covid-19 immunisation and experienced menstrual cycle delayed. On 28Apr2021 at 07:00, the patient experienced Pain and soreness in arm at injection site down through to fingers, redness welt at injection site, headache, joint and muscle pain, fatigue, 100.8 degree F fever. The patient underwent lab tests and procedures which included body temperature that was 100.8 Fahrenheit on 28Apr2021. Therapeutic measures were taken as a result of the events with ibuprofen and vitamins. The clinical outcome of the events was resolving.  No follow-up attempts are Possible. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Pain and soreness in arm at injection site down through to fingers; redness welt at injection site; headache; joint and muscle pain; joint and muscle pain; fatigue; 100.8°F fever; Pain and soreness in arm at injection site down through to fingers; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 47-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0171), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 at 10:15 (age at vaccination: 47 year) as dose 2, single for covid-19 immunisation. Medical history included migraine headache, allergen induced asthma from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (IBUPROFEN) and cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) both were taken for an unspecified indication, start and stop date were not reported. If other vaccine in four weeks reported as no. other medication reported as ibuprofen, Zyrtec. Known allergies reported as no. If covid prior vaccination and If covid tested post vaccination reported as no. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0151), dose 1 via an unspecified route of administration, administered in Arm Left on 06Apr2021 10:15 (age at vaccination: 47 year) as dose 1, single for covid-19 immunisation and experienced menstrual cycle delayed. On 28Apr2021 at 07:00, the patient experienced Pain and soreness in arm at injection site down through to fingers, redness welt at injection site, headache, joint and muscle pain, fatigue, 100.8 degree F fever. The patient underwent lab tests and procedures which included body temperature that was 100.8 Fahrenheit on 28Apr2021. Therapeutic measures were taken as a result of the events with ibuprofen and vitamins. The clinical outcome of the events was resolving.  No follow-up attempts are Possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Pain in extremity, Tenderness
Clinical narrative: walking caused her to limp; left hip pain appeared localized to left greater trochanteric area with moderate to severe increasing intensity/Pain continued and ongoing, radiation to left anterior thigh and knee/; Pain continued and ongoing for 7 days till 28Apr2021, radiation to left anterior thigh and knee; point tenderness on left greater trochanteric projection; This is a spontaneous report from a contactable physician (patient). A 74-years-old female non-pregnant patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8727 and Expiration date was not reported) via an unspecified route of administration, administered in left arm on 14Apr2021 at 08:00 hours as dose 1, single for COVID-19 immunization. Medical history included chronic left low lumbar back pain, minimal prior to vaccination day. Patient had no known allergies. The patient's concomitant medications were not reported. Patient was not diagnosed with COVID-19, prior to vaccination and had not been tested for COVID-19, post vaccination. Patient had no other vaccine in four weeks. On 21Apr2021 at 07:00 hours, 7th day after Pfizer vaccination, patient experienced left hip pain appeared localized to left greater trochanteric area with moderate to severe increasing intensity, (no pain on my usual left lumbar), pain continued and ongoing for 7 days (28Apr2021), radiation to left anterior thigh and knee, point tenderness on left greater trochanteric projection. At height of pain (28Apr2021), walking caused her to limp from pain. Therapeutic measures were taken as a result of events and some relief with oral ibuprofen maximum 600-800 mg per dose with reduced interval as week went by from frequency of every 6 to 4 hours. Temporary relief with additional supplement of patch analgesic & warm compress. Patient continued to self-medicate if needed and will request postponement of second dose on 05May2021 to 28th week depending on her recovery. The outcome of limping was unknown and outcome of rest of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Pain, Pain in extremity
Clinical narrative: 99.8 F fever; body aches, particularly in my joints; Fatigue; Body aches; Sore arm the night of the vaccine, lasting approximately 48 hours on both shots; This is a spontaneous report from a non-contactable consumer (patient).  A 35-years old male patient received BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number EW0170) via unspecified route of administration in left arm as dose 2, single on 27Apr2021 at 15.45 for covid-19 immunization. The patient age at vaccination was 35-years old. The patient medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 06Apr2021 at 16:15, as a single dose for COVID-19 immunisation and experienced sore arm. The patient experienced minimal side effects from first shot. On an unknown date in Apr2021, the patient experienced Sore arm the night of the vaccine, lasting approximately 48 hours on both shots. On 28Apr2021 at 07:00, the patient experienced 99.8 Fahrenheit fever, body aches particularly in joints and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 28Apr2021, the patient underwent lab tests and procedures which included body temperature and the result was 99.8 Fahrenheit. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events sore arm (lasting approximately 48 hours), 99.8 Fahrenheit fever, body aches particularly in joints and fatigue was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 99.8 F fever; body aches, particularly in my joints; Fatigue; Body aches; Sore arm the night of the vaccine, lasting approximately 48 hours on both shots; This is a spontaneous report from a non-contactable consumer (patient).  A 35-years old male patient received BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number EW0170) via unspecified route of administration in left arm as dose 2, single on 27Apr2021 at 15.45 for covid-19 immunization. The patient age at vaccination was 35-years old. The patient medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 06Apr2021 at 16:15, as a single dose for COVID-19 immunisation and experienced sore arm. The patient experienced minimal side effects from first shot. On an unknown date in Apr2021, the patient experienced Sore arm the night of the vaccine, lasting approximately 48 hours on both shots. On 28Apr2021 at 07:00, the patient experienced 99.8 Fahrenheit fever, body aches particularly in joints and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 28Apr2021, the patient underwent lab tests and procedures which included body temperature and the result was 99.8 Fahrenheit. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events sore arm (lasting approximately 48 hours), 99.8 Fahrenheit fever, body aches particularly in joints and fatigue was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Myalgia, Swelling
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731; Expiration Date: Jul2021) via an unspecified route of administration in the right arm on 12Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included exercise induced Exercise induced asthma, polycystic ovarian syndrome and scoliosis. Concomitant medications included birth control (unspecified), salbutamol (ALBUTEROL) and paracetamol (TYLENOL) taken within two weeks of vaccination from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204; Expiration Date: Jun2021) via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation and reported that on 06Apr2021 lymph node on left clavicle swelled, reduced by 15Apr2021. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, the patient experienced painful swelling in right armpit, pain had continued for 4 days, extending into muscles of right arm on an unknown date in Apr2021. On 28Apr2021, the patients lymph node on right clavicle swelled. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events was not recovered.No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urticaria
Clinical narrative: Urticaria everywhere except feet and face; This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the arm left on 08Apr2021 at 13:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression and bipolar II disorder. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) at a dose of 20mg once daily (QD) and oxcarbazepine (MANUFACTURER UNKNOWN) 300mg two times in a day (BID) both were taken for unspecified indication since unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 03:00, the patient experienced urticaria everywhere except feet and face lasting 24 hours. On 29Apr2021, the patient underwent a SARS-CoV-2 virus test (nasal swab: colour through work) and the result was unknown (pending at the time of the report). The patient did not receive any treatment for the reported events. The events results in Emergency room/department or urgent care. The clinical outcome of the event urticaria everywhere except feet and face was recovered on 21Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Insomnia, Nausea, Pain
Clinical narrative: Severe body ache; Lack of sleep; Fever of 100.9; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection;Lot Number: EW0169) via an unspecified route of administration in the arm left on 27Apr2021(at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on 08Apr2021 (2 days after the first dose of vaccine). Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. No known allergies.Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) dose 1 for COVID-19 immunisation and tested positive for COVID-19. On 28Apr2021 at 04:30 (about 12 hours after vaccination), the patient experienced severe body ache, a fever of 100.9, chills, and nausea, which ultimately led to a lack of sleep. All these lasted for 12 hours thereafter (28Apr2021). On 08Apr2021, the patient underwent COVID-19 virus test and the result was positive. On 28Apr2021, the patient got his body temperature checked and the result was fever of 100.9. Therapeutic measures were taken as a result of events and included treatment with tylenol PM and then aleve. The clinical outcome of the event severe body ache, fever of 100.9, chills, nausea and lack of sleep was resolved on 28Apr2021 at 16:30.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Severe body ache; Lack of sleep; Fever of 100.9; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection;Lot Number: EW0169) via an unspecified route of administration in the arm left on 27Apr2021(at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on 08Apr2021 (2 days after the first dose of vaccine). Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. No known allergies.Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) dose 1 for COVID-19 immunisation and tested positive for COVID-19. On 28Apr2021 at 04:30 (about 12 hours after vaccination), the patient experienced severe body ache, a fever of 100.9, chills, and nausea, which ultimately led to a lack of sleep. All these lasted for 12 hours thereafter (28Apr2021). On 08Apr2021, the patient underwent COVID-19 virus test and the result was positive. On 28Apr2021, the patient got his body temperature checked and the result was fever of 100.9. Therapeutic measures were taken as a result of events and included treatment with tylenol PM and then aleve. The clinical outcome of the event severe body ache, fever of 100.9, chills, nausea and lack of sleep was resolved on 28Apr2021 at 16:30.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Ear congestion, Nasal congestion, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; stuffed nose; ear congestion; 101 fever; This is a spontaneous report from a contactable consumer (patient). A 31-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date: Not reported), via an unspecified route of administration into left arm on 29Apr2021 at 13:15 (at the age of 31-year-old) as dose 2, single for COVID-19 immunization at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included Anxiety, depression, and Bipolar II. The patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medications (in two weeks of vaccination) included: Citalopram at 20 mg once a day (QD), and Oxcarbazepine 300 mg twice a day (BID). The patient has received an unspecified vaccine on 29Apr2021. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: Solution for injection, Lot number: EW0158, expiry date: Not reported), via an unspecified route of administration into left arm on 08Apr2021 at 13:15 (at the age of 31-year-old) as dose 1, single for COVID-19 immunization and had Urticaria everywhere except feet and face on 20Apr2021 at 03:00 AM which lasted 24 hours. Patient did not receive prior vaccinations within 4 weeks. On 29Apr2021, the patient had Sore throat, stuffed nose, 101 fever, and ear congestion 7 hours after vaccination. Patient tested for COVID-19 post vaccination. The patient visited Emergency room/department or urgent care. The lab data on 29Apr2021 included: Covid tested post vaccination with Nasal Swab (Colour - through work) and results were pending at the time of reporting and body temperature was noted 101. The patient did not receive any treatment for adverse events. The outcome of events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Sore throat; stuffed nose; ear congestion; 101 fever; This is a spontaneous report from a contactable consumer (patient). A 31-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date: Not reported), via an unspecified route of administration into left arm on 29Apr2021 at 13:15 (at the age of 31-year-old) as dose 2, single for COVID-19 immunization at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included Anxiety, depression, and Bipolar II. The patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medications (in two weeks of vaccination) included: Citalopram at 20 mg once a day (QD), and Oxcarbazepine 300 mg twice a day (BID). The patient has received an unspecified vaccine on 29Apr2021. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: Solution for injection, Lot number: EW0158, expiry date: Not reported), via an unspecified route of administration into left arm on 08Apr2021 at 13:15 (at the age of 31-year-old) as dose 1, single for COVID-19 immunization and had Urticaria everywhere except feet and face on 20Apr2021 at 03:00 AM which lasted 24 hours. Patient did not receive prior vaccinations within 4 weeks. On 29Apr2021, the patient had Sore throat, stuffed nose, 101 fever, and ear congestion 7 hours after vaccination. Patient tested for COVID-19 post vaccination. The patient visited Emergency room/department or urgent care. The lab data on 29Apr2021 included: Covid tested post vaccination with Nasal Swab (Colour - through work) and results were pending at the time of reporting and body temperature was noted 101. The patient did not receive any treatment for adverse events. The outcome of events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Anosmia
Clinical narrative: lost sense of smell; This is a spontaneous report from a contactable consumer or other non hcp via Pfizer Sponsored Program . A male patient of an unspecified age received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date patient experienced lost sense of smell. It was reported that no patient identifiers were provided- it was unknown if the reporter had a specific patient in mind. Swap from  Pharmacy with patient who lost sense of smell just hours after receiving first CoVax dose. Asked if there was any information on that. The outcome of the event was unknown.  No follow-up attempts are required. Information about lot/batch number cannot be obtained. No further information is expected.   .
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: swollen lymph nodes; Swelling under left eye; Leg pain in both legs; This is a spontaneous report from a contactable consumer(patient). A 77-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the right arm on 15Feb2021 at 13:30 (at the age of 77-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on unspecified date as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin from unknown date and unknown if ongoing. Concomitant medication within two weeks of vaccination included multivitamin (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021, the patient experienced leg pain in both legs and still had the pain at the time of this report. On 9Mar2021, the patient experienced Swelling under left eye. On 10Mar2021 at 20:00, the patient experienced swollen lymph nodes right armpit after Shot 2. That is when she noticed and felt them. She was very concerned 10Mar2021. The patient did not receive any treatment for the events. The clinical outcome of the events Lymphadenopathy, Pain in extremity was not resolved at the time of this report while the outcome of the event swelling under left eye was resolved on 10Mar2021. No follow-up attempts are needed. No further information is expected.